Cysteine protease inhibitors

Details for Australian Patent Application No. 2009329066 (hide)

Owner Medivir UK Ltd

Inventors Ayesa, Susana; Belfrage, Anna Karin; Classon, Bjorn; Grabowska, Urszula; Hewitt, Ellen; Ivanov, Vladimir; Jonsson, Daniel; Kahnberg, Pia; Lind, Peter; Nilsson, Magnus; Oden, Lourdes; Pelcman, Mikael; Wahling, Horst

Agent Davies Collison Cave

Pub. Number AU-B-2009329066

PCT Pub. Number WO2010/070615

Priority 08172480.9 19.12.08 EP

Filing date 18 December 2009

Wipo publication date 24 June 2010

Acceptance publication date 24 May 2012

International Classifications

C07D 295/20 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/145 (2006.01) - having sulfur atoms, e.g. thiurams (NC(S)SC(S)N or NC(S)SSC(S)N)

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07C 215/20 (2006.01) Compounds containing amino and hydroxy groups bound to the same carbon skeleton

C07C 235/74 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07C 311/21 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 213/71 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 231/40 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/64 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/80 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 241/12 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 275/00 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

C07D 275/03 Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/070615 Priority application(s): WO2010/070615

24 May 2012 Application Accepted

  Published as AU-B-2009329066

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009329067-Process for the synthesis of L-fucosyl dior oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof

2009329038-Surface modified optically variable product for security feature